7 Einträge gefunden

1. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients

   1. Meng, Xiaodan
   2. Joosse, Simon A
   3. Müller, Volkmar
   4. Trillsch, Fabian
   5. Milde-Langosch, Karin
   6. Mahner, Sven
   7. Geffken, Maria

   2015 - Forschungsinformationssystem des UKE
2. Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer

   1. Mathey, Sabrina
   2. Graeser, Monika Karla
   3. Zu Eulenburg, Christine
   4. Woelber, Linn
   5. Trillsch, Fabian
   6. Jänicke, Fritz
   7. Müller, Volkmar

   2013 - Forschungsinformationssystem des UKE
3. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.

   1. Henningsen, Maike
   2. Kress, Kerstin
   3. Kersten, Jan Felix
   4. Kilic, Ergün
   5. Choschzick, Matthias
   6. Zander, Hilke
   7. Müller, Volkmar

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
4. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.

   1. Kock, Lilli
   2. Mahner, Sven
   3. Choschzick, Matthias
   4. Zu Eulenburg, Christine Gräfin
   5. Milde-Langosch, Karin
   6. Schwarz, Jörg
   7. Jänicke, Fritz

   2011 - Forschungsinformationssystem des UKE
5. Comparison of microarray-based RNA expression with ELISA-based protein determination of HER2, uPA and PAI-1 in tumour tissue of patients with breast cancer and relation to outcome.

   1. Witzel, Isabell
   2. Milde-Langosch, Karin
   3. Wirtz, Ralph M
   4. Roth, Claudia
   5. Henningsen, Maike
   6. Mahner, Sven
   7. Zu Eulenburg, Christine Gräfin

   2010 - Forschungsinformationssystem des UKE
6. Serum carbonic anhydrase IX during first-line therapy of ovarian cancer.

   1. Wölber, Linn
   2. Müller, Volkmar
   3. Zu Eulenburg, Christine Gräfin
   4. Schwarz, Jörg
   5. Carney, Walter
   6. Jänicke, Fritz
   7. Milde-Langosch, Karin

   2010 - Forschungsinformationssystem des UKE
7. TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients.

   1. Mahner, Sven
   2. Wölber, Linn
   3. Zu Eulenburg, Christine Gräfin
   4. Schwarz, Jörg
   5. Carney, Walter
   6. Jänicke, Fritz
   7. Milde-Langosch, Karin

   2010 - Forschungsinformationssystem des UKE - frei zugänglich